-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dxh2sg/izojOBHQOzqO7DKnXsgvgpiLEa8gbbqUWnHtvQGSyVwc7Rpv18JtY7Kop 5IZU29j5XHFbc4Xr93oHRA== 0000000000-09-022310.txt : 20090612 0000000000-09-022310.hdr.sgml : 20090612 20090428115211 ACCESSION NUMBER: 0000000000-09-022310 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090428 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 PUBLIC REFERENCE ACCESSION NUMBER: 0001193125-08-043592 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@-S0X M-"]/(#@O12`S,C8V+TX@,2]4(#!BZ=1=;Y`!%?2!K``(P,# MCQI4FQ40LS(P2/V!B#-\`0@P`"X%!X4-"F5N9'-T7!E+T-A=&%L M;V7!E+U!A9V4^/@UE;F1O8FH-.2`P(&]B:@T\/"]&;VYT/#PO5%0R(#$P M(#`@4B]45#0@,3(@,"!2/CXO4')O8U-E=%LO4$1&+U1E>'1=+T5X=$=3=&%T M93P\+T=3,2`Q-2`P(%(^/CX^#65N9&]B:@TQ,"`P(&]B:@T\/"]3=6)T>7!E M+U1R=654>7!E+T9O;G1$97-C7!E+T9O M;G0^/@UE;F1O8FH-,3$@,"!O8FH-/#PO3&5N9W1H(#NX(:3+[B#]\-[B2R9* M6+?U,T3,9?;8<^)0X1'H_]2-/P!U&&.N^F;6K9!X\2P1S9M/P6,LT2:SH)E1W#^2+=."[^),UL*:1$Q-!$2(FU38#^BN]L7:!M<-\:+LUKT0M MT33G<"=Y(S:\HJ$3D!8RL]C`U5;P`E:BRJI<9"5\*PK\7(Z`H]ZAR``O2OY7 MU!7<;3.YHW,$RG*^;T6>E0T-G#F94B*''MQ6==LBSU** M%SZ,WNO)NBBNMKS9"LFG<$5CQR-U5?$3^\C6 MZPW5/;\$S*T7LG&(Q^BF@Z`&E=19#PP((GAQZ**GJUKNP&6S6RBP#.V6PT^> M2;BN-GP#2TYG$=?::ACC&Y(P]1 MJ#\X;#,48%[OGDO>8GSU7H+D+X*_0EW`06VUURZ^+LC"SHI'I9?.B2HX5A:Q M;['+-HA59@JW$*6HGAIUAJWG$<-;U5U..OCA>^(>_?8-18'-Y9,]=7&4J">I M_*:)XQ(SAC_O26AR,Q=1,;SJ(F??U_,M\^A8?O;M1%`EZUSM1 M:'8[#5S2MP?K@I[N;&S.Z/A>38.`.^N$;,Q]>7+11][G^.C@0F,A16,][1<] M?G_2VI/,`NM7!E+T9O;G0^/@UE;F1O8FH-,3,@ M,"!O8FH-/#PO4W1E;58@.#(O1F]N=$YA;64O5&EM97-.97=2;VUA;E!3350O M1F]N=%-T%LM-38X("TS,#<@,C`P,"`Q,#`W72]!7!E+T9O;G1$97-C%LM M-34X("TS,#<@,C`P,"`Q,#(V72]!7!E M+T9O;G1$97-C'1'4W1A=&4O M4T$@9F%L7!E+UA-3"],96YG=&@@,S8Q,B]4>7!E+TUE=&%D M871A/CYS=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP M0V5H:4AZDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O M8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#0N,"UC,S$V M(#0T+C(U,SDR,2P@4W5N($]C="`P,2`R,#`V(#$W.C$T.C,Y(CX*("`@/')D M9CI21$8@>&UL;G,Z&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R M9R]D8R]E;&5M96YT"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M($%L97AI;VX@ M3D9#($QE='1E&%P34TZ26YS=&%N M8V5)1#YU=6ED.F(T,#0P9#,W+69F-6$M-#&%P34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^ M"B`@(#PO&EO;B!.1D,@3&5T=&5R(#0R M.#`Y+F1O8RD^/@UE;F1O8FH->')E9@T*,"`V#0HP,#`P,#`P,#`P(#8U-3,U M(&8-"C`P,#`P,#,R-C8@,#`P,#`@;@T*,#`P,#`P,S,P,"`P,#`P,"!N#0HP M,#`P,#`S,S(T(#`P,#`P(&X-"C`P,#`P,#,S-S4@,#`P,#`@;@T*,#`P,#`P M-S`V-"`P,#`P,"!N#0IT -----END PRIVACY-ENHANCED MESSAGE-----